The risk of developing liver cancer is increased in people who have cirrhosis, a disease in which healthy liver tissue is replaced by scar tissue. The scar tissue blocks the flow of blood through the liver and keeps it from functioning as it should, and patients with advanced liver cancer and cirrhosis are normally considered unsuitable for surgery or transplant.
In a new study published in the British Journal of Surgery, researchers describe successful tumor removal using immunotherapy and targeted radiation therapy (TARE), in a patient previously considered ineligible for the procedure.
"Our study describes how a minimally invasive surgical approach known as the Arantius-first technique, can be applied in high-risk populations, potentially expanding surgical indications for patients with cirrhosis," explains corresponding author Eduardo Vega, MD, assistant professor of surgery at Boston University Chobanian & Avedisian School of Medicine.
Know more: https://www.sciencedaily.com/releases/2025/02/2502...

• Tags:
• News